SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Gufic Biosciences gets nod to amalgamate Gufic Lifesciences with itself

21 Sep 2018 Evaluate

Gufic Biosciences has received an approval for the scheme of amalgamation of Gufic Lifesciences with the company and their respective shareholders and creditors. The Board of Directors of the company at its meeting held on September 20, 2018 has approved the same.

Gufic Lifesciences primarily engaged in the business of manufacturing of pharmaceutical formulations. The company has its main focus on developing life-saving injectables at its EU-GMP certified manufacturing facility located at Naysari, Gujarat and is the one of the largest manufacturer of Lyophilised injections.

Gufic Biosciences is engaged in diversified business viz. Pharma, Healthcare, Bio- Technology, Seeds, Herbal etc.

Gufic Biosciences Share Price

301.30 -1.35 (-0.45%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×